Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
SZSE:002932.SZ
21.72 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| 69.216 | 4,380.471 | 1,446.688 | 475.628 | 42.507 | 62.468 | 65.554 | 59.692 | 35.597 | 21.54 | 7.322 | 1.402 | 0.253 |
| Depreciation & Amortization
| 83.4 | 59.078 | 23.626 | 17.238 | 16.775 | 13.188 | 9.555 | 4.275 | 1.577 | 0.817 | 0.268 | 0.096 | 0.054 |
| Deferred Income Tax
| -27.71 | -130.485 | -7.019 | -6.681 | -1.121 | 1.28 | 0.267 | 0.479 | 0.514 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 9.439 | 27.932 | 76.806 | 29.815 | 0 | 0 | 0 | 0 | 4.504 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 269.135 | -1,389.391 | -365.992 | -139.718 | -33.588 | -20.812 | -28.826 | -5.16 | 3.668 | -6.08 | -1.215 | -0.612 | -0.896 |
| Accounts Receivables
| 1,255.646 | -2,324.756 | -722.319 | -320.046 | -4.121 | -21.219 | -16.393 | -8.53 | -1.061 | -6.48 | -1.434 | -0.237 | 0 |
| Inventory
| 342.822 | -473.38 | -166.862 | -78.575 | -19.474 | -4.819 | -5.741 | -0.206 | -0.856 | -1.834 | -4.73 | -1.273 | -0.075 |
| Accounts Payables
| -1,301.622 | 1,539.229 | 530.209 | 265.585 | -8.872 | 3.945 | -6.959 | 3.097 | 5.071 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 79.952 | -130.485 | -7.019 | -6.681 | -1.121 | -15.993 | -23.085 | -4.954 | 4.524 | -4.245 | 3.515 | 0.661 | -0.82 |
| Other Non Cash Items
| 20.817 | 1,065.244 | -47.103 | -16.6 | -3.208 | -1.173 | 0.214 | 0.053 | 4.18 | 0.197 | -0.079 | 0.147 | 0.106 |
| Operating Cash Flow
| 392.498 | 4,012.848 | 1,127.006 | 359.682 | 22.486 | 53.671 | 46.496 | 58.859 | 45.022 | 16.474 | 6.296 | 1.033 | -0.483 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -109.974 | -313.38 | -103.567 | -28.284 | -31.938 | -47.478 | -45.517 | -40.274 | -1.181 | -4.238 | -2.734 | -0.583 | -0.124 |
| Acquisitions Net
| 0.146 | 1,920.82 | 0 | 28.292 | 31.938 | 47.478 | 45.517 | 40.274 | 1.181 | 4.238 | 0 | 0 | 0 |
| Purchases Of Investments
| -5,209.837 | -6,308 | -2,208 | -844.5 | -600 | -450 | -120 | -125 | -161 | -21.8 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 3,954.598 | 4,387.18 | 1,626.449 | 829.407 | 534.669 | 292.968 | 146.453 | 100.535 | 183.506 | 0.237 | 0 | 0 | 0 |
| Other Investing Activites
| -1,255.092 | -1,920.82 | 0 | -28.284 | -31.938 | -47.478 | -45.517 | -40.274 | -1.181 | -4.238 | -2.734 | -0.583 | -0.124 |
| Investing Cash Flow
| -1,365.066 | -2,234.199 | -685.118 | -43.369 | -97.268 | -204.51 | -19.063 | -64.739 | 21.326 | -25.802 | -2.734 | -0.583 | -0.124 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| -101.386 | -53.418 | -141.5 | -141.5 | -2.788 | -5.388 | -6.719 | -4.842 | 0 | -1 | -0.9 | -0.9 | -0.35 |
| Common Stock Issued
| 0 | 0 | -2.599 | 0 | 0 | -3.916 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| -0.532 | 0 | 2.599 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -577.401 | -548.772 | -282.937 | -6.659 | -19.976 | -26.634 | 0 | 0 | -4.09 | -2.525 | -0.053 | -0.083 | -0.051 |
| Other Financing Activities
| 13.809 | 171.263 | 507.167 | 332.864 | 0.496 | 320.361 | 8.642 | -2.815 | 24.484 | 16.941 | 2.85 | 0.9 | 0.95 |
| Financing Cash Flow
| -670.06 | -432.79 | 82.272 | 182.921 | -22.268 | 293.727 | 8.642 | -2.815 | 20.393 | 13.416 | 1.897 | -0.083 | 0.549 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 1.262 | 19.471 | -3.196 | -0.639 | 0.006 | 0.006 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -1,641.365 | 1,365.33 | 520.964 | 498.596 | -97.044 | 142.895 | 36.075 | -8.695 | 86.741 | 4.089 | 5.46 | 0.366 | -0.057 |
| Cash At End Of Period
| 914.04 | 2,555.405 | 1,190.075 | 669.111 | 170.515 | 267.559 | 124.664 | 88.589 | 97.284 | 10.543 | 6.454 | 0.995 | 0.629 |